Zitter Health Insights Access Answered.

Prostate Cancer

Pharmacy & Therapeutics (P&T) Perspective

From this 120-minute simulated P&T Committee syndicated research product you will gain insights on:

  • How P&T members will manage the dynamic mCRPC space
  • Whether management techniques will be utilized in this growing category now or in the near future
  • How management  and treatment decisions may be affected if Xtandi gains indication for pre-chemotherapy treatment
  • The reactions of committee members to oral route of administration
  • How management may be affected if Zytiga becomes available as generic
  • How contracting may influence the committee’s management decisions